相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
B. Christensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease
C. S. Tse et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Stefan Schreiber et al.
JOURNAL OF GASTROENTEROLOGY (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
Primary sclerosing cholangitis - a comprehensive review
Tom H. Karlsen et al.
JOURNAL OF HEPATOLOGY (2017)
Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease
W. A. Bye et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Primary Sclerosing Cholangitis
Konstantinos N. Lazaridis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease
P. Luthra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis
Kirsten Boonstra et al.
HEPATOLOGY (2013)
Primary sclerosing cholangitis
Gideon M. Hirschfield et al.
LANCET (2013)
Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease
J. Torres et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
John E. Eaton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Gut Homing Receptors on CD8 T Cells Are Retinoic Acid Dependent and Not Maintained by Liver Dendritic or Stellate Cells
Bertus Eksteen et al.
GASTROENTEROLOGY (2009)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
K Burak et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis
B Eksteen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease
AJ Grant et al.
LANCET (2002)
MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)
AJ Grant et al.
HEPATOLOGY (2001)
分享论文
